Bahram Valamehr

Insider Reports History

Entity
Individual
Location
C/O Fate Therapeutics, Inc., 3535 General Atomics Court, Ste 200, San Diego, CA
Signature
/s/ Cindy R. Tahl, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bahram Valamehr:

Stock Role Class Num Shares Value Price $ Report Date Ownership
FATE THERAPEUTICS INC Chief R&D Officer Common Stock 358K $2.78M $7.77 Jul 29, 2024 Direct
FATE THERAPEUTICS INC Chief R&D Officer Stock Option (Right to Buy) 450K $1.23M $2.73 Feb 1, 2024 Direct

Insider Reports Filed by Bahram Valamehr

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FATE FATE THERAPEUTICS INC Jul 29, 2024 1 $0 4 Jul 31, 2024 Chief R&D Officer
FATE FATE THERAPEUTICS INC Feb 1, 2024 1 $0 4 Feb 2, 2024 Chief R&D Officer
FATE FATE THERAPEUTICS INC Jan 9, 2024 1 -$49.4K 4 Jan 10, 2024 Chief R&D Officer
FATE FATE THERAPEUTICS INC Feb 6, 2023 1 $0 4 Feb 7, 2023 Chief R&D Officer
FATE FATE THERAPEUTICS INC Jan 12, 2023 2 $580 4 Jan 13, 2023 Chief R&D Officer
FATE FATE THERAPEUTICS INC Jan 10, 2023 1 -$57.2K 4 Jan 11, 2023 Chief R&D Officer
FATE FATE THERAPEUTICS INC Jul 7, 2022 3 -$519K 4 Jul 8, 2022 Chief R&D Officer
FATE FATE THERAPEUTICS INC Jul 6, 2022 5 -$236K 4 Jul 7, 2022 Chief R&D Officer
FATE FATE THERAPEUTICS INC Mar 14, 2022 7 -$708K 4 Mar 15, 2022 Chief R&D Officer
FATE FATE THERAPEUTICS INC Jan 25, 2022 2 $0 4 Jan 27, 2022 Chief Research & Development Officer
FATE FATE THERAPEUTICS INC Jan 11, 2022 2 -$222K 4 Jan 13, 2022 Chief R&D Officer
FATE FATE THERAPEUTICS INC Jan 10, 2022 2 -$260K 4 Jan 12, 2022 Chief R&D Officer
FATE FATE THERAPEUTICS INC Dec 13, 2021 7 -$1.12M 4 Dec 14, 2021 Chief R&D Officer
FATE FATE THERAPEUTICS INC Nov 19, 2021 1 $0 4 Nov 22, 2021 Chief R&D Officer
FATE FATE THERAPEUTICS INC Sep 13, 2021 5 -$1.59M 4 Sep 14, 2021 Chief Development Officer
FATE FATE THERAPEUTICS INC Jun 14, 2021 7 -$2.16M 4 Jun 16, 2021 Chief Development Officer